000 01391 a2200361 4500
005 20250517112411.0
264 0 _c20170210
008 201702s 0 0 eng d
022 _a1950-6112
024 7 _a10.1684/abc.2016.1154
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEclache, Virginie
245 0 0 _aCytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
_h[electronic resource]
260 _bAnnales de biologie clinique
_cOct 2016
300 _a525-534 p.
_bdigital
500 _aPublication Type: Journal Article; Practice Guideline; Review
650 0 4 _aComparative Genomic Hybridization
650 0 4 _aCytogenetic Analysis
_xmethods
650 0 4 _aFrance
650 0 4 _aHematology
_xorganization & administration
650 0 4 _aHigh-Throughput Nucleotide Sequencing
650 0 4 _aHumans
650 0 4 _aIn Situ Hybridization, Fluorescence
650 0 4 _aMyelodysplastic Syndromes
_xdiagnosis
650 0 4 _aSocieties, Medical
_xstandards
700 1 _aLafage-Pochitaloff, Marina
700 1 _aLefebvre, Christine
700 1 _aPenther, Dominique
700 1 _aRaynaud, Sophie
700 1 _aTigaud, Isabelle
773 0 _tAnnales de biologie clinique
_gvol. 74
_gno. 5
_gp. 525-534
856 4 0 _uhttps://doi.org/10.1684/abc.2016.1154
_zAvailable from publisher's website
999 _c26347626
_d26347626